Cohance Lifesciences Ltd Board of Directors
Board of Directors at Cohance Lifesciences Ltd
K Ananthakrishnan
Independent Director
Kundan Jha
Company Sec. & Compli. Officer
Matangi Gowrishankar
Independent Director
Pankaj Patwari
Non Executive Director
Shweta Jalan
Non Executive Director
Key Highlights
- Umang Vohra joins the board as Chairman & Group CEO, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Shweta Jalan joins the board as Non Executive Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Pankaj Patwari joins the board as Non Executive Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Vinod Padikkal continues to serve as the Non-Exec & Non-Independent Dir in 2026, maintaining the same position as in the previous year.
- Matangi Gowrishankar continues to serve as the Independent Non Exe. Director in 2026, maintaining the same position as in the previous year.
Cohance Lifesciences Ltd
NSE: COHANCE
Share Price
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 06 Oct 2026 | 457.05 |
| 05 Oct 2026 | 446.75 |
| 01 Oct 2026 | 451.45 |
| 30 Sep 2026 | 444.2 |
| 29 Sep 2026 | 456.75 |
| 28 Sep 2026 | 453.9 |
| 25 Sep 2026 | 459.05 |
| 24 Sep 2026 | 454.05 |
| 23 Sep 2026 | 461.55 |
| 22 Sep 2026 | 452.4 |
Company Fundamentals for Cohance Lifesciences Ltd
Market Cap
17,486 Cr
EPS
2.8
P/E Ratio (TTM)
162.6
P/B Ratio (TTM)
4.5
Day’s High
459.55
Day’s Low
446.85
DTE
0.1
ROE
5.0
52 Week High
917.5
52 Week Low
267.85
ROCE
5.5
Market Price of Cohance Lifesciences Ltd
1M
1Y
3Y
5Y
Monitoring Cohance Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Cohance Lifesciences Ltd News Hub
Suven Pharmaceuticals consolidated net profit declines 49.61% in the June 2024 quarter
Net profit of Suven Pharmaceuticals declined 49.61% to Rs 60.77 crore in the quarter ended June 2024
Read more
09 Aug 24
Suven Pharmaceuticals to hold board meeting
Suven Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 August 2024.
Read more
06 Aug 24
Suven Pharmaceuticals appoints Vivek Sharma as new Executive Chairman
Suven Pharmaceuticals announced the appointment of Vivek Sharma as the new Executive Chairman, effec
Read more
19 Sept 24
Board of Suven Pharmaceuticals approves change in Executive Chairperson
The Board of Suven Pharmaceuticals at its meeting held on 19 September 2024 has taken on record the
Read more
19 Sept 24
Document
Annual Reports
N/A
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
FAQs for Board of Directors of Cohance Lifesciences Ltd
How are members of Cohance Lifesciences Ltd Board of Directors selected?
Members of the Cohance Lifesciences Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Cohance Lifesciences Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the Cohance Lifesciences Ltd Board of Directors?
Shareholders can interact with the Cohance Lifesciences Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the Cohance Lifesciences Ltd Board of Directors meet?
The Cohance Lifesciences Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the Cohance Lifesciences Ltd Board of Directors?
The Cohance Lifesciences Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at Cohance Lifesciences Ltd?
The current Board of Directors at Cohance Lifesciences Ltd includes Umang Vohra( Chairman & Group CEO) ,Shweta Jalan( Non Executive Director) ,Pankaj Patwari( Non Executive Director) ,Vinod Padikkal( Non-Exec & Non-Independent Dir) ,Matangi Gowrishankar( Independent Non Exe. Director) . The full list can be found on Cohance Lifesciences Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
